___

• Kaynaklar 1.Thong B. Vervloet D. Drug Allergies. URL: http://www.worldal-lergy.org/professional/ allergic_diseases_center/drugallergy/.January, 20072.Kelso JM, Greenhawt MJ, Li JT, et al. Adverse reactions to vac-cines practice parameter 2012 update. J Allergy Clin Immunol2012;130:25-43. 3.Chung EH. Vaccine allergies. Clin Exp Vaccine Res. 2014Jan;3(1):50-7. 4.Bethesda, MD. National Asthma Education and PreventionProgram: Expert panel report III: Guidelines for the diagnosisand management of asthma.: National Heart, Lung, and BloodInstitute, 2007. 5.National Asthma Education and Prevention Program: Expert pa-nel report III: Guidelines for the diagnosis and management ofasthma. Bethesda, MD: National Heart, Lung, and Blood Insti-tute,2007.(NIHpublicationno.08-4051). www.nhlbi.nih.gov/gui-delines/asthma/asthgdln.htm (Accessed on December 04, 2014). 6.The safety of inactivated influenza vaccine in adults and child-ren with asthma. N Engl J Med 2001; 345:1529. 7.Cates CJ, Rowe BH. Vaccines for preventing influenza in peop-le with asthma. Cochrane Database Syst Rev 2013; 2:CD000364. 8.Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Kar-ron RA. Prevention and Control of Influenza with Vaccines: Re-commendations of the Advisory Committee on Immunization Prac-tices, United States, 2015-16 Influenza Season. MMWR Morb Mor-tal Wkly Rep. 2015;64(30):818. 9.Thompson MG, Clippard J, Petrie JG, Jackson ML, McLean HQ,Gaglani M, Reis EC, Flannery B, Monto AS, Jackson L, Belon-gia EA, Murthy K, Zimmerman RK, Thaker S, Fry AM. Influen-za Vaccine Effectiveness for Fully and Partially Vaccinated Child-ren 6 Months to 8 Years Old During 2011-2012 and 2012-2013:The Importance of Two Priming Doses. Pediatr Infect Dis J.2016;35(3):299. 10.Nuorti JP, Whitney CG, Centers for Disease Control and Pre-vention (CDC). Prevention of pneumococcal disease among in-fants and children - use of 13-valent pneumococcal conjugate vac-cine and 23-valent pneumococcal polysaccharide vaccine - re-commendations of the Advisory Committee on Immunization Prac-tices (ACIP). MMWR Recomm Rep 2010; 59:1. 11.Kasper WJ, Howe PM. Fatal varicella after a single course of cor-ticosteroids. Pediatr Infect Dis J. 1990 Oct;9(10):729-32. 12.Silk HJ, Guay-Woodford L, Perez-Atayde AR, Geha RS, Broff MD.Fatal varicella in steroid-dependent asthma. J Allergy Clin Im-munol. 1988 Jan;81(1):47-51. 13.Centers for Disease Control and Prevention. Varicella. In: Epide-miology and Prevention of Vaccine-Preventable Diseases. The PinkBook: Course Textbook, 13th ed, Hamborsky J, Kroger A, WolfeS, (Eds). Public Health Foundation, Washington, DC 2015.http://www.cdc.gov/vaccines/pubs/pinkbook/index.html 14.Verstraeten T, Jumaan AO, Mullooly JP, Seward JF, Izurieta HS,DeStefano F, Black SB, Chen RT; Vaccine Safety Datalink Re-search Group. A retrospective cohort study of the association ofvaricella vaccine failure with asthma, steroid use, age at vacci-nation, and measles-mumps-rubella vaccination. Pediatrics.2003 Aug;112(2):e98-103. 15.Centers for Disease Control and Prevention (CDC). Syncope af-ter vaccination--United States, January 2005-July 2007. MMWRMorb Mortal Wkly Rep. 2008 May 2;57(17):457-60. 16.Taylor SL, Hefler SL, Bindslev-Jensen C, Bock SA, Burks Jr AW,Christie L, et al.Factors affecting the determination of thresholddoses for allergenic foods:how much is too much? J Allergy ClinImmunol. 2002;109:24–30. 17.Erlewyn-Lajeunesse M, Hunt LP, Heath PT, Finn A. Anaphyla-xis as an adverse event following immunisation in the UK and Ire-land. Arch Dis Child.2012;97:487–90. 18.Andersen DV, Jørgensen IM. MMR vaccination of children withegg allergy is safe. Dan Med J. 2013;60:A4573. 19.James JM, Burks AW, Roberson PK, Sampson HA. Safe admi-nistration of the measles vaccine to children allergic to eggs. NEngl J Med. 1995;332(19):1262. 20.Sakaguchi M, Ogura H, Inouye S. IgE antibody to gelatin in child-ren with immediate-type reactions to measles and mumps vacci-nes. J Allergy Clin Immunol. 1995 Oct;96(4):563-5. 21.Sakaguchi M, Inouye S Systemic allergic reactions to gelatin in-cluded in vaccines as a stabilizer. Jpn J Infect Dis. 2000Oct;53(5):189-95. 22.Kelso JM. Potential food allergens in medications. J Allergy ClinImmunol.2014;133:1509–18. 23.Li JT, Rank MA, Squillace DL, Kita H. Ovalbumin content of in-fluenza vaccines. J Allergy Clin Immunol. 2010;125:1412–3. 24.Des Roches A, Paradis L, Gagnon R, Lemire C, Begin P, CarrS, et al. Egg-allergic patients can be safely vaccinated againstinfluenza. J Allergy Clin Immunol. 2012;130:1213–5. 25.Kattan JD, Konstantinou GN, Cox AL, et al. Anaphylaxis to dipht-heria, tetanus, and pertussis vaccines among children with cow'smilk allergy. J Allergy Clin Immunol 2011; 128:215. 26.DiMiceli L, Pool V, Kelso JM, Shadomy SV, Iskander J, VAERSTeam. Vaccination of yeast sensitive individuals: review of sa-fety data in the US vaccine adverse event reporting system (VA-ERS). Vaccine. 2006;24:703–7.27.Kelso JM. Potential food allergens in medications. J Allergy ClinImmunol.2014;133:1509–18. 28.Herman JJ, Radin R, Schneiderman R. Allergic reactions to me-asles (rubeola) vaccine in patients hypersensitive to egg prote-ins. J Pediatr. 1983;102:196–199 29.Kelso JM, Jones RT, Yunginger JW. Anaphylaxis to measles,mumps, and rubella vaccine mediated by IgE to gelatin. J AllergyClin Immunol. 1993;91:867–872 30.Sakaguchi M, Nakayama T, Inouye S. Food allergy to gelatin inchildren with systemic immediate-type reactions, includinganaphylaxis, to vaccines.J Allergy Clin Immunol.1996;98:1058–1061 31.Bogdanovic J, Halsey NA, Wood RA, Hamilton RG. Bovine andporcine gelatin sensitivity in children sensitized to milk and meat.J Allergy Clin Immunol. 2009;124:1108–10. 32.Mullins RJ, James H, Platts-Mills TA, Commins S. Relationshipbetween red meat allergy and sensitization to gelatin and galac-tose-α-1,3-galactose. J Allergy Clin Immunol. 2012;129:1334–42. 33.Giordano-Labadie F, Rance F, Pellegrin F, et al.: Frequencyof contact allergy in children with atopic dermatitis: results ofa prospective study of 137 cases. Contact Dermatitis 1999,40:192–195. 34.Wollenberg A, Vogel S, Renner ED. Vaccinations with atopic der-matitis and other chronic inflammatory skin diseases. Hautarzt.2010 Nov;61(11):985-93 35.Gruber C, Warner J, Hill D et al (2008) Early atopic disease andearly child-hood immunization – is there a link? Allergy63:1464–1472. 36.P, Stephenson TJ: Systemic exposure, tolerability and effi cacyof pimecrolimus cream 1% in atopic dermatitis patients. Arch DisChild 2003; 88: 969–973.37. 37.. Papp KA, Breuer K, Meurer M, Ortonne JP, Potter PC, deProst Y, Davidson MJ, Barbier N, Goertz HP, Paul C: Long-termtreatment of atopic dermatitis with pimecrolimus cream 1% ininfants does not interfere with the development of protective an-tibodies after vaccination J Am Acad Dermatol 2005; 52:247–253. 38.Stiehm ER, Roberts RL, Kaplan MS, Corren J: Tacrolimus oint-ment does not alter immune responses of eczematous children.J Allergy Clin Immunol 2003; 111:S355. 39.Wollenberg A, Oranje A, Deleuran M, Simon D, Szalai Z, KunzB, Svensson A, Barbarot S, von Kobyletzki L, Taieb A, de Bru-in-Weller M, Werfel T, Trzeciak M, Vestergard C, Ring J, Dar-sow U; European Task Force on Atopic Dermatitis/EADV Ec-zema Task Force.ETFAD/EADV Eczema task force 2015 posi-tion paper on diagnosis and treatment of atopic dermatitis in adultand paediatric patients. J Eur Acad Dermatol Venereol. 2016May;30(5):729-47. 40.Goyal A, Goyal K, Merola JF. Screening and vaccinations in pa-tients requiring systemic immunosuppression: an update for der-matologists. Am J Clin Dermatol. 2015 Jun;16(3):179-95. 41.Russel M, Pool V, Kelso JM, Tomazic-Jezic VJ. Vaccination ofpersons allergic to latex: a review of safety data in the VaccineAdverse Event Reporting Sistem (VAERS). Vaccine.2004;23:664–6. 42.Lear JT, English JS. Anaphylaxis after hepatitis B vaccination.Lancet 1995;345:1249.43.Offit P, Jew R. Addressing parents' concerns: do vaccines con-tain harmful preservatives, adjuvants, additives, or residuals? Pe-diatrics 2003;112(6 Pt 1):1394-7 44.Hem SL. Elimination of aluminum adjuvants. Vaccine 2002;20:S40-3. 45.King K, Paterson M, Green SK. Global justice and the proposedban on thimerosal containing vaccines. Pediatrics.2013;131:154–6. 46.Cox NH, Forsyth A. Thimerosal allergy and vaccination reacti-ons. Contact Dermatitis 1988;18:229-33. 47.Fitzgerald KA, Davies A, Russell AD. Mechanism of action of chlor-hexidine diacetate and phenoxyethanol singly and in combinati-on against gram-negative bacteria. Microbios 1992;70: 215-3 48.Georgitis JW, Fasano MB. Allergenic components of vaccines andavoidance of vaccination-related adverse events. Curr Allergy Rep.2001 Jan;1(1):11-7. 49.McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS; Centers forDisease Control and Prevention. Prevention of measles, rubella,congenital rubella syndrome, and mumps, 2013: summary recom-mendations of the Advisory Committee on Immunization Practi-ces (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.